Advanced search
Publication Cover
Dialogues in Clinical Neuroscience Volume 6, 2004 - Issue 3
Submit an article Journal homepage
7,748
Views
297
CrossRef citations to date
0
Altmetric
State of the Art

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder

Biología de la enfermedad de Parkinson: patogénesis y fisiopatología de un trastorno neurodegenerativo multisistémico

Biologie de la maladie de Parkinson: pathogenèse et physiopathologie d'un trouble neurodégénératif multisystémique

Garrett E. AlexanderDepartment of Neurology, Emory University School of Medicine, Atlanta, Ga, USACorrespondence[email protected]
Pages 259-280 | Published online: 01 Apr 2022

Citations (297)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Chang-Long He, Yong Tang, Jian-Ming Wu, Tao Long, Lu Yu, Jin-Feng Teng, Wen-Qiao Qiu, Rong Pan, Chong-Lin Yu, Da-Lian Qin, An-Guo Wu & Xiao-Gang Zhou. (2023) Chlorogenic acid delays the progression of Parkinson's disease via autophagy induction in Caenorhabditis elegans. Nutritional Neuroscience 26:1, pages 11-24.
Read now
Soha Ramadan, Manal M. Sabry, Muhammed A Saad, Simone Angeloni, Omar M. Sabry, Giovanni Caprioli & Soheir M. El Zalabani. (2022) Dismantling Parkinson’s disease with herbs: MAO-B inhibitory activity and quantification of chemical constituents using HPLC-MS/MS of Egyptian local market plants. Natural Product Research 36:22, pages 5766-5771.
Read now
Ali Reza Khalatbary & Emad Khademi. (2020) The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection. Nutritional Neuroscience 23:4, pages 281-294.
Read now
Ahmed Elkamhawy, Sora Paik, Hyeon Jeong Kim, Jong-Hyun Park, Ashwini M. Londhe, Kyeong Lee, Ae Nim Pae, Ki Duk Park & Eun Joo Roh. (2020) Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1568-1580.
Read now
Roozbeh Behroozmand & Karim Johari. (2019) Sensorimotor Impairment of Speech and Hand Movement Timing Processing in Parkinson’s Disease. Journal of Motor Behavior 51:5, pages 561-571.
Read now
Mani Sugumar, Murugan Sevanan & Sathiya Sekar. (2019) Neuroprotective effect of naringenin against MPTP-induced oxidative stress. International Journal of Neuroscience 129:6, pages 534-539.
Read now
Alireza Abdanipour, Fatemeh Deheshjo, Davood Sohrabi, Iraj Jafari Anarkooli & Reza Nejatbakhsh. (2018) Neuroprotective effect of lovastatin through down-regulation of pro-apoptotic Mst1 gene expression in rat model pilocarpine epilepsy. Neurological Research 40:10, pages 874-882.
Read now
Pawanrat Chalorak, Prapaporn Jattujan, Saksit Nobsathian, Tanate Poomtong, Prasert Sobhon & Krai Meemon. (2018) Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing. Nutritional Neuroscience 21:6, pages 427-438.
Read now
Rahul Dev Jayant, Daniela Sosa, Ajeet Kaushik, Venkata Atluri, Arti Vashist, Asahi Tomitaka & Madhavan Nair. (2016) Current status of non-viral gene therapy for CNS disorders. Expert Opinion on Drug Delivery 13:10, pages 1433-1445.
Read now
Yahya E. Choonara, Pradeep Kumar, Girish Modi & Viness Pillay. (2016) Improving drug delivery technology for treating neurodegenerative diseases. Expert Opinion on Drug Delivery 13:7, pages 1029-1043.
Read now
Kah-Leong Lim. (2010) Non-mammalian animal models of Parkinson's disease for drug discovery. Expert Opinion on Drug Discovery 5:2, pages 165-176.
Read now

Articles from other publishers (286)

Arpana Parihar, Palak Sharma, Nishant Kumar Choudhary & Raju Khan. 2024. Smart Diagnostics for Neurodegenerative Disorders. Smart Diagnostics for Neurodegenerative Disorders 1 38 .
Satinder Kaur, Abhishek Sehrawat, Sarabjit Singh Mastana, Ramesh Kandimalla, Pushpender Kumar Sharma, Gurjit Kaur Bhatti & Jasvinder Singh Bhatti. (2023) Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease. Life Sciences 330, pages 121995.
Crossref
Zofia Kinga Bytowska, Daria Korewo-Labelle, Konrad Kowalski, Witold Libionka, Katarzyna Przewłócka, Wojciech Kloc & Jan Jacek Kaczor. (2023) Impact of 12 Weeks of Vitamin D3 Administration in Parkinson’s Patients with Deep Brain Stimulation on Kynurenine Pathway and Inflammatory Status. Nutrients 15:17, pages 3839.
Crossref
Amandeep Kaur, Navneet Singh, Harmanpreet Kaur, Violina Kakoty, Deep Shikha Sharma, Rubiya Khursheed, Molakpogu Ravindra Babu, Vancha Harish, Gaurav Gupta, Monica Gulati, Puneet Kumar, Harish Dureja, Nahed S. Alharthi, Farhan R. Khan, Zia ur Rehman, Mohammed Ageeli Hakami, Mrunali Patel, Rashmin Patel, Milad Zandi, Sukriti Vishwas, Kamal Dua & Sachin Kumar Singh. (2023) Neurodegenerative diseases and brain delivery of therapeutics: Bridging the gap using dendrimers. Journal of Drug Delivery Science and Technology 87, pages 104868.
Crossref
Joana Silva, Celso Alves, Francisca Soledade, Alice Martins, Susete Pinteus, Helena Gaspar, Amparo Alfonso & Rui Pedrosa. (2023) Marine-Derived Components: Can They Be a Potential Therapeutic Approach to Parkinson’s Disease?. Marine Drugs 21:8, pages 451.
Crossref
Meng Jin, Ruidie Shi, Daili Gao, Baokun Wang, Ning Li, Xia Li, Attila Sik, Kechun Liu & Xiujun Zhang. (2023) ErbB2 pY ‐1248 as a predictive biomarker for Parkinson's disease based on research with RPPA technology and in vivo verification . CNS Neuroscience & Therapeutics.
Crossref
Bilal El-Mansoury, Omar El Hiba, Mustapha Agnaou, Arumugam Radhakrishan Jayakumar, Abdelaati El Khiat, Kholoud Kahim, Samira Boulbaroud, Nadia Zouhairi, Oumaima Tibssirte, Hayat Bouighajd, Moulay Abdelmonaim El Hidan, Abdesslam Ferssiwi & Abdelali Bitar. 2023. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease 82 101 .
Claire Chrysanthi Karpodini, Themistoklis Tsatalas, Ioannis Giannakopoulos, Mattias Romare, Giannis Giakas, Panagiotis V. Tsaklis, Petros C. Dinas, Aline Nogueira Haas, Sokratis G. Papageorgiou, Efthalia Angelopoulou, Matthew A. Wyon & Yiannis Koutedakis. (2023) The Effects of a Single Session of a Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients: A Methodological Approach. Medicina 59:8, pages 1408.
Crossref
Weikai Li, Yongxiang Tang, Liling Peng, Zhengxia Wang, Shuo Hu & Xin Gao. (2023) The reconfiguration pattern of individual brain metabolic connectome for Parkinson's disease identification. MedComm 4:4.
Crossref
Christina Kousparou, Maria Fyrilla, Anastasis Stephanou & Ioannis Patrikios. (2023) DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases. International Journal of Molecular Sciences 24:13, pages 10717.
Crossref
Yuan-Wei Yan, Eddie S Qian, Lauren E Woodard & Julie Bejoy. (2023) Neural lineage differentiation of human pluripotent stem cells: Advances in disease modeling. World Journal of Stem Cells 15:6, pages 530-547.
Crossref
Zofia Kinga Bytowska, Daria Korewo-Labelle, Paweł Berezka, Konrad Kowalski, Katarzyna Przewłócka, Witold Libionka, Wojciech Kloc & Jan Jacek Kaczor. (2023) Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson’s Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites. International Journal of Molecular Sciences 24:12, pages 10200.
Crossref
Vinayak Majhi, Bishnu Choudhury, Goutam Saha & Sudip Paul. (2023) The Behavioural Analysis of the <i>Dosha</i> Pattern Derived from Associated Current Diseases and Symptoms along with Parkinson’s Disease. Journal of Natural Remedies, pages 475-485.
Crossref
Nasya Thompson, Michael MacAskill, Maddie Pascoe, Tim Anderson & Campbell Le Heron. (2023) Dimensions of apathy in Parkinson's disease. Brain and Behavior 13:6.
Crossref
Elena Paccosi & Luca Proietti-De-Santis. (2023) Parkinson’s Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy. International Journal of Molecular Sciences 24:11, pages 9547.
Crossref
Andrea Antonosante, Vanessa Castelli, Martina Sette, Margherita Alfonsetti, Mariano Catanesi, Elisabetta Benedetti, Matteo Ardini, Annamaria Cimini & Michele d’Angelo. (2023) Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models. Biological Research 56:1.
Crossref
P. Jenner, C. Falup-Pecurariu, V. Leta, M. Verin, M. Auffret, Roongroj Bhidayasiri, D. Weiss, F. Borovečki & W. H. Jost. (2023) Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease. Journal of Neural Transmission.
Crossref
Tapan Behl, Piyush Madaan, Aayush Sehgal, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Abdulkarim M. Meraya, Md. Khalid Anwer & Raman Verma. (2023) Understanding the Molecular Aspects of Vitamins in Parkinson’s Disease: Present-day Concepts and Perspectives. Current Pharmaceutical Design 29:19, pages 1467-1485.
Crossref
Priya Chaudhary, Debasis Mitra, Pradeep K. Das Mohapatra, Anca Oana Docea, Ei Mon Myo, Pracheta Janmeda, Miquel Martorell, Marcello Iriti, Manshuk Ibrayeva, Javad Sharifi-Rad, Antonello Santini, Raffaele Romano, Daniela Calina & William C. Cho. (2023) Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications. Arabian Journal of Chemistry 16:5, pages 104680.
Crossref
Kiana Rafiepour, Ali Salehzadeh, Pouyan Bahadori, Saeed Esmaeili-Mahani & Marzieh Maneshian. (2023) Abscisic acid decreases expression of COX-2 and TNF-α proteins in SH-SY5Y neuroblastoma cells as an in vitro model of Parkinson's disease. Neuroscience and Behavioral Physiology 53:4, pages 688-694.
Crossref
Rosaria De Luca, Mirjam Bonanno, Elisabetta Morini, Angela Marra, Francesca Antonia Arcadi, Angelo Quartarone & Rocco Salvatore Calabrò. (2023) Sexual Dysfunctions in Females with Parkinson’s Disease: A Cross-Sectional Study with a Psycho-Endocrinological Perspective. Medicina 59:5, pages 845.
Crossref
Rodrigo Tavares Brisson, Rita de Cássia Leite Fernandes, Josevânia Fulgêncio de Lima Arruda, Thiffanny Cristini Cassiano da S. M. Rocha, Nathália de Góes Duarte Santos, Liene Duarte Silva, Marco Antônio Sales Dantas de Lima & Ana Lucia Zuma de Rosso. (2023) Altered Cerebral Vasoreactivity on Transcranial Color-Coded Sonography Related to Akinetic-Rigid Phenotype of Parkinson’s Disease: Interim Analysis of a Cross-Sectional Study. Brain Sciences 13:5, pages 709.
Crossref
Ilene Trinh, Angeni Muralidhar, Justin Yang & Nicolás Phielipp. (2023) Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease. Movement Disorders Clinical Practice.
Crossref
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, Preeti Patel & Vivek Asati. (2023) Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach. Molecular Diversity.
Crossref
Jae Woo Chung, Christopher A. Knight, Abigail E. Bower, Justin P. Martello, John J. Jeka & Roxana G. Burciu. (2023) Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson’s disease. PLOS ONE 18:3, pages e0282203.
Crossref
Anna Favaro, Laureano Moro-Velázquez, Ankur Butala, Chelsie Motley, Tianyu Cao, Robert David Stevens, Jesús Villalba & Najim Dehak. (2023) Multilingual evaluation of interpretable biomarkers to represent language and speech patterns in Parkinson's disease. Frontiers in Neurology 14.
Crossref
Lilian do Amaral, Neife Aparecida Guinaim dos Santos, Flávia Malvestio Sisti, Elaine Del Bel & Antônio Cardozo dos Santos. (2023) Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Jessica IChi Lai, Alessandra Porcu, Benedetto Romoli, Maria Keisler, Fredric P. Manfredsson, Susan B. Powell & Davide Dulcis. (2023) Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model. International Journal of Molecular Sciences 24:4, pages 4204.
Crossref
Sanghoon Kim, Edward Pajarillo, Ivan Nyarko-Danquah, Michael Aschner & Eunsook Lee. (2023) Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants. Cells 12:4, pages 622.
Crossref
Pravat K. Mandal, Rimil Guha Roy & Avinash Kalyani. (2023) Distribution Pattern of Closed and Extended Forms of Glutathione in the Human Brain: MR Spectroscopic Study. ACS Chemical Neuroscience 14:2, pages 270-276.
Crossref
Tian-Shuo Yuan, Ying-Chuan Chen, De-Feng Liu, Ruo-Yu Ma, Xin Zhang, Ting-Ting Du, Guan-Yu Zhu & Jian-Guo Zhang. (2023) Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease. Neural Regeneration Research 18:4, pages 901.
Crossref
Jae Woo Chung, Abigail E. Bower, Ibrahim Malik, Justin P. Martello, Christopher A. Knight, John J. Jeka & Roxana G. Burciu. (2023) Imaging the lower limb network in Parkinson’s disease. NeuroImage: Clinical 38, pages 103399.
Crossref
Natalie Lipari, Ashley Centner, John Glinski, Sophie Cohen, Fredric P. Manfredsson & Christopher Bishop. (2023) Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease. Neurobiology of Disease 176, pages 105965.
Crossref
Hager H. Mousa, Maha H. Sharawy & Manar A. Nader. (2023) Empagliflozin enhances neuroplasticity in rotenone-induced parkinsonism: Role of BDNF, CREB and Npas4. Life Sciences 312, pages 121258.
Crossref
M. Muralidhara. 2023. Ayurvedic Herbal Preparations in Neurological Disorders. Ayurvedic Herbal Preparations in Neurological Disorders 1 40 .
Rohil Hameed, Anam Naseer, Pranoy Toppo, Mahmood Akbar, Sakshi Yadav & Aamir Nazir. 2023. Ayurvedic Herbal Preparations in Neurological Disorders. Ayurvedic Herbal Preparations in Neurological Disorders 303 329 .
Zehra Batool, Asia Azfal, Laraib Liaquat, Sadia Sadir, Rida Nisar, Aimen Inamullah, Asad Ullah Faiz Ghalib & Saida Haider. 2023. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders 117 185 .
Gino A. Kurian. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 41 61 .
Leonel Pereira & Ana Valado. 2023. Functional Ingredients from Algae for Foods and Nutraceuticals. Functional Ingredients from Algae for Foods and Nutraceuticals 553 564 .
Sima Biswas & Angshuman Bagchi. (2022) Study of the Effects of Nicotine and Caffeine for the Treatment of Parkinson’s Disease. Applied Biochemistry and Biotechnology 195:1, pages 639-654.
Crossref
Ravichandran Manjupriya, Kamalanathan Pouthika, Gunabalan Madhumitha & Selvaraj Mohana Roopan. (2022) Biological aspects of nitrogen heterocycles for amyotrophic lateral sclerosis. Applied Microbiology and Biotechnology 107:1, pages 43-56.
Crossref
Sabrina Schaly & Satya Prakash. 2023. Gut Microbiota in Aging and Chronic Diseases. Gut Microbiota in Aging and Chronic Diseases 193 213 .
Feixiang Bao, Lingyan Zhou, Jiahui Xiao & Xingguo Liu. (2022) Mitolysosome exocytosis: a novel mitochondrial quality control pathway linked with parkinsonism-like symptoms. Biochemical Society Transactions 50:6, pages 1773-1783.
Crossref
Maria Rosa Avila-Costa, Mariana Stephania Rodríguez-Alcántara, Ana Luisa Gutierréz-Valdez, José Luis Ordoñez-Librado, Vianey Rodríguez-Lara, Leonardo Reynoso-Erazo, Claudia Dorado-Martínez, Cesar Alfonso Garcia Caballero, Enrique Montiel-Flores, Javier Sanchez-Betancourt, Rocío Tron-Alvarez, Patricia Aley-Medina & Jesús Espinosa-Villanueva. 2022. Melatonin - Recent Updates. Melatonin - Recent Updates.
Masoumeh Salimian, Mahmoud Reza Sohrabi & Saeed Mortazavinik. (2022) Application of net analyte signal and principal component regression for rapid simultaneous determination of Levodopa and carbidopa in commercial pharmaceutical formulation and breast (human) milk sample using spectrophotometric method. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 283, pages 121741.
Crossref
Irin Sultana Nila, Dewan Md. Sumsuzzman, Zeeshan Ahmad Khan, Jin Ho Jung, Ashura Suleiman Kazema, Sang Jin Kim & Yonggeun Hong. (2022) Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: A systematic review and meta-analysis. Ageing Research Reviews 82, pages 101764.
Crossref
Chuang-Hsin Chiu, Shao-Ju Weng, Skye Hsin-Hsien Yeh, Yun-Ting Jhao, Hsien-Feng Chang, Wen-Sheng Huang, Cheng-Yi Cheng, Chun-Chang Yeh & Kuo-Hsing Ma. (2022) Assessment of the anti-nociceptive effects of fetal ventral mesencephalic tissue allografts in a rat model of hemi-Parkinson’s disease using fMRI. Frontiers in Aging Neuroscience 14.
Crossref
Shan Zhong, Jeong Woo Choi, Nadia G. Hashoush, Diana Babayan, Mahsa Malekmohammadi, Nader Pouratian & Vassilios Christopoulos. (2022) A neurocomputational theory of action regulation predicts motor behavior in neurotypical individuals and patients with Parkinson’s disease. PLOS Computational Biology 18:11, pages e1010111.
Crossref
Nesibe Peker, Mridula Sharma & Ravi Kambadur. (2022) Parkin deficiency exacerbates fasting-induced skeletal muscle wasting in mice. npj Parkinson's Disease 8:1.
Crossref
Ahsanullah Yunas Mahmoud, Daniel Neagu, Daniele Scrimieri & Amr Rashad Ahmed Abdullatif. (2022) Review of Immunotherapy Classification: Application Domains, Datasets, Algorithms and Software Tools from Machine Learning Perspective. Review of Immunotherapy Classification: Application Domains, Datasets, Algorithms and Software Tools from Machine Learning Perspective.
Meenakshi Kandpal, Omkar Indari, Budhadev Baral, Shweta Jakhmola, Deeksha Tiwari, Vasundhra Bhandari, Rajan Kumar Pandey, Kiran Bala, Avinash Sonawane & Hem Chandra Jha. (2022) Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders. Metabolites 12:11, pages 1064.
Crossref
Fan Xu, Xian-wei Zou, Li-qiong Yang, Shi-cong Mo, Quan-hao Guo, Jing Zhang, Xiechuan Weng & Guo-gang Xing. (2022) Facial muscle movements in patients with Parkinson's disease undergoing phonation tests. Frontiers in Neurology 13.
Crossref
Fabian J. David, Yessenia M. Rivera, Tara K. Entezar, Rishabh Arora, Quentin H. Drane, Miranda J. Munoz, Joshua M. Rosenow, Sepehr B. Sani, Gian D. Pal, Leonard Verhagen-Metman & Daniel M. Corcos. (2022) Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's disease. Frontiers in Neurology 13.
Crossref
Bibhuti Bhusan Kakoti, Rajashri Bezbaruah & Nasima Ahmed. (2022) Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues. Frontiers in Pharmacology 13.
Crossref
Tingting Wang, Nasra Yasin, Salman Zubedat, Yelena Loboda, Avi Avital, Levi Schachter & John P.M. Finberg. (2022) Exposure to static magnetic field facilitates selective attention and neuroplasticity in rats. Brain Research Bulletin 189, pages 111-120.
Crossref
Sinyeon Kim, Jin Gyu Choi, Se Woong Kim, Sang Cheol Park, Yu-ra Kang, Dong Seok Park, Miwon Son & Choong Hwan Lee. (2022) Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson’s disease. Biomedicine & Pharmacotherapy 154, pages 113637.
Crossref
Mohammad Rumman, Shivani Pandey, Babita Singh, Mrinal Gupta & Abbas Ali Mahdi. (2022) Genistein suppresses microglial activation and inhibits apoptosis in different brain regions of hypoxia-exposed mice model of amnesia. Metabolic Brain Disease 37:7, pages 2521-2532.
Crossref
L. Presotto, V. Bettinardi, D. Mercatelli, M. Picchio, M. Morari, R. M. Moresco & Sara Belloli. (2022) Development of a new toolbox for mouse PET–CT brain image analysis fully based on CT images and validation in a PD mouse model. Scientific Reports 12:1.
Crossref
Hsin-Hsuan Liu, Ray-Yau Wang, Shih-Jung Cheng, Kwong-Kum Liao, Jun-Hong Zhou & Yea-Ru Yang. (2022) Balance Training Modulates Cortical Inhibition in Individuals with Parkinson’s Disease: A Randomized Controlled Trial. Neurorehabilitation and Neural Repair 36:9, pages 613-620.
Crossref
Hsin-Hsuan Liu, Ray-Yau Wang, Shih-Jung Cheng, Kwong-Kum Liao, Jun-Hong Zhou & Yea-Ru Yang. (2022) Effects of square-stepping exercise on executive function in individuals with Parkinson's disease: A randomized controlled pilot study. Geriatric Nursing 47, pages 273-279.
Crossref
Jackson Tyler Boonstra, Hugo McGurran, Yasin Temel & Ali Jahanshahi. (2022) Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review. Brain Structure and Function 227:7, pages 2231-2242.
Crossref
Claire Chrysanthi Karpodini, Petros C. Dinas, Efthalia Angelopoulou, Matthew A. Wyon, Aline Nogueira Haas, Maria Bougiesi, Sokratis G. Papageorgiou & Yiannis Koutedakis. (2022) Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis. Frontiers in Neurology 13.
Crossref
Sarfraj Ahmad Siddiqui, Bentham Science Publisher Habiba & Md Arshad. 2022. Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition). Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition) 71 87 .
Shivam Kumar, Lav Goyal & Shamsher Singh. (2022) Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors. CNS & Neurological Disorders - Drug Targets 21:7, pages 596-609.
Crossref
Yuen-Fann Ng, Celeste Yan-Teng Chen, Gerald Teck-Heng Chia, Brendan Bryan Jen-Wei Tan, Ling-Ling Chan & Eng-King Tan. (2022) The association between Parkinson’s disease and Sexual dysfunction: Clinical correlation and therapeutic implications. Ageing Research Reviews 79, pages 101665.
Crossref
Aoji Xie, Elizabeth Ensink, Peipei Li, Juozas Gordevičius, Lee L. Marshall, Sonia George, John Andrew Pospisilik, Velma T.E. Aho, Madelyn C. Houser, Pedro A.B. Pereira, Knut Rudi, Lars Paulin, Malú G. Tansey, Petri Auvinen, Patrik Brundin, Lena Brundin, Viviane Labrie & Filip Scheperjans. (2022) Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms. Movement Disorders 37:8, pages 1644-1653.
Crossref
Ziqing Wei, Mingze Wei, Xiaoyu Yang, Yuming Xu, Siqi Gao & Kaidi Ren. (2022) Synaptic Secretion and Beyond: Targeting Synapse and Neurotransmitters to Treat Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Murad Al-Nusaif, Yuting Yang, Song Li, Cheng Cheng & Weidong Le. (2022) The role of NURR1 in metabolic abnormalities of Parkinson’s disease. Molecular Neurodegeneration 17:1.
Crossref
Eugene Huh, Youngji Kwon, Jin Gyu Choi, Myung Gyu Lim, Jin Seok Jeong, Ah Yeon Park, Jeong Hee Kim, Youngmi Kim Pak, Seon-Pyo Hong & Myung Sook Oh. (2022) DA-9805, a Herbal Mixture, Restores Motor Manifestations in 6-Hydroxydopamine-induced Parkinson’s Disease Mouse Model by Regulating Striatal Dopamine and Acetylcholine Levels. Frontiers in Pharmacology 13.
Crossref
Arun Upadhyay, Naveen Sundaria, Rohan Dhiman, Vijay Kumar Prajapati, Amit Prasad & Amit Mishra. (2021) Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges. The Neuroscientist 28:3, pages 271-282.
Crossref
Qinhong Huang, Canming Liao, Fan Ge, Jian Ao & Ting Liu. (2022) Acetylcholine bidirectionally regulates learning and memory. Journal of Neurorestoratology 10:2, pages 100002.
Crossref
Eugenia Landolfo, Debora Cutuli, Laura Petrosini & Carlo Caltagirone. (2022) Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans. Biomolecules 12:5, pages 667.
Crossref
Shashank Masaldan, Sylvie Callegari & Grant Dewson. (2022) Therapeutic targeting of mitophagy in Parkinson's disease. Biochemical Society Transactions 50:2, pages 783-797.
Crossref
Jing Lu, Xian Wang, Anxin Wu, Yi Cao, Xiaolin Dai, Youdan Liang & Xiaofang Li. (2022) Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics. Phytotherapy Research 36:4, pages 1523-1544.
Crossref
Mary F. Nakamya, Susmita Sil, Shilpa Buch & Ramin M. Hakami. (2022) Mitochondrial Extracellular Vesicles in CNS Disorders: New Frontiers in Understanding the Neurological Disorders of the Brain. Frontiers in Molecular Biosciences 9.
Crossref
Luca Mesin, Paola Porcu, Debora Russu, Gabriele Farina, Luigi Borzì, Wei Zhang, Yuzhu Guo & Gabriella Olmo. (2022) A Multi-Modal Analysis of the Freezing of Gait Phenomenon in Parkinson’s Disease. Sensors 22:7, pages 2613.
Crossref
Nidaa A. Ababneh, Ban Al-Kurdi, Fatima Jamali & Abdalla Awidi. (2022) A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells. PeerJ 10, pages e13003.
Crossref
Luis Varela & Maria E. R. Garcia-Rendueles. (2022) Oncogenic Pathways in Neurodegenerative Diseases. International Journal of Molecular Sciences 23:6, pages 3223.
Crossref
Meena S. Subbarayan, Aurelie Joly-Amado, Paula C. Bickford & Kevin R. Nash. (2022) CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases. Pharmacology & Therapeutics 231, pages 107989.
Crossref
Sonat Pınar Kara, Bengü Altunan & Aysun Unal. (2021) Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system. Neurological Sciences 43:3, pages 1799-1807.
Crossref
Nour S. Erekat & Muhammed D. Al-Jarrah. (2022) Endurance exercise training suppresses myostatin upregulation and nuclear factor-kappa B activation in a mouse model of Parkinson's disease. Veterinary World, pages 383-389.
Crossref
Rashi Rajput, Ramneek Kaur, Rishika Chadha, Shalini Mani, Rachana R.Harleen Kaur & Manisha Singh. 2022. Research Anthology on Supporting Healthy Aging in a Digital Society. Research Anthology on Supporting Healthy Aging in a Digital Society 110 132 .
Xin Li, Xiaoying Fan, Hongtian Yang & Yufeng Liu. (2021) Review of Metabolomics-Based Biomarker Research for Parkinson’s Disease. Molecular Neurobiology 59:2, pages 1041-1057.
Crossref
Teresa Alberts, Veronica Antipova, Carsten Holzmann, Alexander Hawlitschka, Oliver Schmitt, Jens Kurth, Jan Stenzel, Tobias Lindner, Bernd J. Krause, Andreas Wree & Martin Witt. (2022) Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease. Toxins 14:2, pages 94.
Crossref
YiYang Shen. (2022) Investigating the Mechanism of Chemical Drugs on Neurodegenerative Diseases. Investigating the Mechanism of Chemical Drugs on Neurodegenerative Diseases.
Anna Picca, Flora Guerra, Riccardo Calvani, HélioJosé Coelho-Junior, Cecilia Bucci & Emanuele Marzetti. (2022) Circulating extracellular vesicles: friends and foes in neurodegeneration. Neural Regeneration Research 17:3, pages 534.
Crossref
Joshua Crawford, Sufang Liu & Feng Tao. (2022) Gut microbiota and migraine. Neurobiology of Pain 11, pages 100090.
Crossref
Chloe Lopez-Lee, Lay Kodama & Li Gan. (2022) Sex Differences in Neurodegeneration: The Role of the Immune System in Humans. Biological Psychiatry 91:1, pages 72-80.
Crossref
Akhlaq A. Farooqui. 2022. Neuroinflammation, Resolution, and Neuroprotection in the Brain. Neuroinflammation, Resolution, and Neuroprotection in the Brain 121 160 .
V. Valadez-Barba, A. Cota-Coronado, C.P. Barragán-Álvarez, E. Padilla-Camberos & N.E. Díaz-Martínez. 2022. Novel Concepts in iPSC Disease Modeling. Novel Concepts in iPSC Disease Modeling 59 84 .
Saba Shahzadi, Muhammad Yasir, Bisma Aftab, Sumbal Babar & Mubashir Hassan. 2022. Computer Simulations of Aggregation of Proteins and Peptides. Computer Simulations of Aggregation of Proteins and Peptides 449 467 .
Nikita Aggarwal, Barjinder Singh Saini & Savita Gupta. (2021) The impact of clinical scales in Parkinson’s disease: a systematic review. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57:1.
Crossref
Marwa M. Safar, Noha F. Abdelkader, Eman Ramadan, Mona A. Kortam & Ahmed F. Mohamed. (2021) Novel mechanistic insights towards the repositioning of alogliptin in Parkinson's disease. Life Sciences 287, pages 120132.
Crossref
Analia Bortolozzi, Sharon Manashirov, Alon Chen & Francesc Artigas. (2021) Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease. Pharmacology & Therapeutics 227, pages 107873.
Crossref
Kevin Lançon, Chaoling Qu, Edita Navratilova, Frank Porreca & Philippe Séguéla. (2021) Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain. Cell Reports 37:9, pages 109933.
Crossref
Pradeep Kumar, Dipendra Kumar Mahato, Madhu Kamle, Rituraj Borah, Bharti Sharma, Shikha Pandhi, Vijay Tripathi, Hardeo Singh Yadav, Sheetal Devi, Umesh Patil, Jianbo Xiao & Awdhesh Kumar Mishra. (2021) Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview . Phytotherapy Research 35:11, pages 6010-6029.
Crossref
Alvaro C. Lima, Ywlliane S. R. Meurer, Vinicius S. Bioni, Débora M. G. Cunha, Narriman Gonçalves, Leonardo B. Lopes-Silva, Marcela Becegato, Manuela B. L. Soares, Gabriela F. Marinho, José R. Santos & Regina H. Silva. (2021) Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease. Frontiers in Aging Neuroscience 13.
Crossref
Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein & John B. Furness. (2021) ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease. Journal of Parkinson's Disease 11:4, pages 1821-1832.
Crossref
Xiumin Liu, Weiwei Liu, Chenkang Wang, Yinzhe Chen, Panwen Liu, Toshihiko Hayashi, Kazunori Mizuno, Shunji Hattori, Hitomi Fujisaki & Takashi Ikejima. (2021) Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy. Physiology & Behavior 239, pages 113510.
Crossref
Anshuman Mohapatra, Vijay Singh Bohara, Sachin Kumar & Nitin Chaudhary. (2021) Polymyxin B accelerates the α-synuclein aggregation. Biophysical Chemistry 277, pages 106628.
Crossref
Mariarosaria D'Errico, Eleonora Parlanti, Barbara Pascucci, Giuseppe Filomeni, Pier Giorgio Mastroberardino & Eugenia Dogliotti. (2021) The interplay between mitochondrial functionality and genome integrity in the prevention of human neurologic diseases. Archives of Biochemistry and Biophysics 710, pages 108977.
Crossref
Min Cheol Chang, Jin-Sung Park, Byung Joo Lee & Donghwi Park. (2021) The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson’s Disease: A Narrative Review. Dysphagia 36:5, pages 786-799.
Crossref
Alexandre Iarkov, Cristhian Mendoza & Valentina Echeverria. (2021) Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease. Frontiers in Neuroscience 15.
Crossref
Harini Sri Rethinavel, Sowbarnika Ravichandran, Risna Kanjirassery Radhakrishnan & Mahesh Kandasamy. (2021) COVID-19 and Parkinson’s disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia. Journal of Chemical Neuroanatomy 115, pages 101965.
Crossref
Ashish Singh, Arun Kumar Yadawa, Swati Chaturvedi, M. Wahajuddin, Amit Mishra & Sarika Singh. (2021) Mechanism for antiParkinsonian effect of resveratrol: Involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis. Food and Chemical Toxicology 155, pages 112433.
Crossref
Konstantina Tetorou, Claudia Sisa, Arzo Iqbal, Kim Dhillon & Mariya Hristova. (2021) Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage. Frontiers in Synaptic Neuroscience 13.
Crossref
Miao Xu, JiaYi Zhu, Xian-Dong Liu, Ming-Ying Luo & Nan-Jie Xu. (2021) Roles of physical exercise in neurodegeneration: reversal of epigenetic clock. Translational Neurodegeneration 10:1.
Crossref
Blossom Samuel Affia. (2021) Neurodegeneration- Disease And Dementia. Journal of Biomedical and Allied Research.
Crossref
Anuradha Yadav, Brashket Seth & Rajnish Kumar Chaturvedi. (2020) Brain Organoids: Tiny Mirrors of Human Neurodevelopment and Neurological Disorders. The Neuroscientist 27:4, pages 388-426.
Crossref
Maxime Peralta, Claire Haegelen, Pierre Jannin & John S. H. Baxter. (2021) PassFlow: a multimodal workflow for predicting deep brain stimulation outcomes. International Journal of Computer Assisted Radiology and Surgery 16:8, pages 1361-1370.
Crossref
Jinhua Zhang, Bo Yang, Lilin Luo, Linhui Li, Xuantao Yang, Juanjuan Zhang, Yuxin Xie, Wanpu Wang & Shuaiyao Lu. (2021) Effect of NTN and Lmx1α on the Notch Signaling Pathway during the Differentiation of Human Bone Marrow Mesenchymal Stem Cells into Dopaminergic Neuron-Like Cells. Parkinson's Disease 2021, pages 1-11.
Crossref
Aaron T. BalanaMatthew R. Pratt. (2021) Mechanistic roles for altered O -GlcNAcylation in neurodegenerative disorders . Biochemical Journal 478:14, pages 2733-2758.
Crossref
Joseph Azar, Hisham F. Bahmad, Darine Daher, Maya M. Moubarak, Ola Hadadeh, Alissar Monzer, Samar Al Bitar, Mohamed Jamal, Mohamed Al-Sayegh & Wassim Abou-Kheir. (2021) The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update. International Journal of Molecular Sciences 22:14, pages 7667.
Crossref
Henrik Renner, Katharina J. Becker, Theresa E. Kagermeier, Martha Grabos, Farsam Eliat, Patrick Günther, Hans R. Schöler & Jan M. Bruder. (2021) Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain Organoids. Frontiers in Molecular Neuroscience 14.
Crossref
Upasana Ganguly, Sukhpal Singh, Soumya Pal, Suvarna Prasad, Bimal K. Agrawal, Reena V. Saini & Sasanka Chakrabarti. (2021) Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough. Frontiers in Aging Neuroscience 13.
Crossref
Sarah K. Lotz, Britanie M. Blackhurst, Katie L. Reagin & Kristen E. Funk. (2021) Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Frontiers in Cellular Neuroscience 15.
Crossref
Carmela Conte. (2021) Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4. International Journal of Molecular Sciences 22:13, pages 7135.
Crossref
Sara Amjad, Sabah Nisar, Ajaz A. Bhat, Ab Rauf Shah, Michael P. Frenneaux, Khalid Fakhro, Mohammad Haris, Ravinder Reddy, Zoltan Patay, Joseph Baur & Puneet Bagga. (2021) Role of NAD+ in regulating cellular and metabolic signaling pathways. Molecular Metabolism 49, pages 101195.
Crossref
Anjana Pathania, Rajnish Kumar & Rajat Sandhir. (2021) Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson’s disease model. Biomedicine & Pharmacotherapy 139, pages 111525.
Crossref
Soonsil Hyun & Dongyun Shin. (2021) Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases. Life 11:7, pages 607.
Crossref
Valentina Pasker, Carlos Huerta, Samuel Sainz, Dario Santos & Franco Simini. (2021) PARKIBIP Feedback Wearable Rehabilitation Device: Market Analysis and Enhancements. PARKIBIP Feedback Wearable Rehabilitation Device: Market Analysis and Enhancements.
Ali Jangjou, Amir Hossein Meisami, Kazem Jamali, Mohammad Hadi Niakan, Milad Abbasi, Mostafa Shafiee, Majid Salehi, Ahmad Hosseinzadeh, Ali Mohammad Amani & Ahmad Vaez. (2021) The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication. Journal of Biomedical Science 28:1.
Crossref
Khadga Raj, Pawandeep Kaur, G.D. Gupta & Shamsher Singh. (2021) Metals associated neurodegeneration in Parkinson’s disease: Insight to physiological, pathological mechanisms and management. Neuroscience Letters 753, pages 135873.
Crossref
Sachchida Nand Rai, Divya Mishra, Payal Singh, Emanuel Vamanu & M.P. Singh. (2021) Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases. Biomedicine & Pharmacotherapy 137, pages 111377.
Crossref
Danying Yang, Jun Ying, Xifeng Wang, Tiancheng Zhao, Sungtae Yoon, Yang Fang, Qingcui Zheng, Xing Liu, Wen Yu & Fuzhou Hua. (2021) Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease. Frontiers in Neuroscience 15.
Crossref
Fatema Currim, Jyoti Singh, Anjali Shinde, Dhruv Gohel, Milton Roy, Kritarth Singh, Shatakshi Shukla, Minal Mane, Hitesh Vasiyani & Rajesh Singh. (2021) Exosome Release Is Modulated by the Mitochondrial-Lysosomal Crosstalk in Parkinson’s Disease Stress Conditions. Molecular Neurobiology 58:4, pages 1819-1833.
Crossref
Jacob D. Jones, Holly Timblin, Elizabeth Rahmani, Shania Garrett, Joseph Bunch, Halbert Beaver & Christopher R. Hill. (2021) Physical activity as a mediator of anxiety and cognitive functioning in Parkinson's disease. Mental Health and Physical Activity 20, pages 100382.
Crossref
Bhupesh Vaidya, Kritika Dhamija, Priyanka Guru & Shyam Sunder Sharma. (2021) Parkinson's disease in women: Mechanisms underlying sex differences. European Journal of Pharmacology 895, pages 173862.
Crossref
Nitu Dogra, Ruchi Jakhmola Mani & Deepshikha Pande Katare. (2021) Protein Interaction Studies for Understanding the Tremor Pathway in Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets 19:10, pages 780-790.
Crossref
Yizhou Yu, Marco Travaglio, Rebeka Popovic, Nuno Santos Leal & Luis Miguel Martins. (2021) Alzheimer’s and Parkinson’s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Geriatrics 6:1, pages 10.
Crossref
Fanpeng Zhao, Quillan Austria, Wenzhang Wang & Xiongwei Zhu. (2021) Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo. International Journal of Molecular Sciences 22:2, pages 601.
Crossref
Kentaro Matsuzaki & Yasushi Ohizumi. (2021) Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders. Nutrients 13:1, pages 145.
Crossref
Shivani Rajeev, Sureshkumar Radhakrishnan, Sivakumar Vidhyadharan, Unnikrishnan Menon, Krishnakumar Thankappan & Subramania Iyer. (2021) Videofluoroscopic study of swallowing disorders in patients with parkinsonism. Amrita Journal of Medicine 17:3, pages 93.
Crossref
Sweta Bhoopatiraju & George Grossberg. (2021) Emerging Perspectives in the Diagnosis and Management of Depression and Psychosis in Parkinson's Disease. Neurology 17:2, pages 97.
Crossref
Swathi Kesh, Rajaretinam Rajesh Kannan, Kalaiarasi Sivaji & Anandan Balakrishnan. (2021) Hesperidin downregulates kinases lrrk2 and gsk3β in a 6-OHDA induced Parkinson’s disease model. Neuroscience Letters 740, pages 135426.
Crossref
Swathi Kesh, Rajaretinam Rajesh Kannan & Anandan Balakrishnan. (2021) Naringenin alleviates 6-hydroxydopamine induced Parkinsonism in SHSY5Y cells and zebrafish model. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 239, pages 108893.
Crossref
Laura J. Bailey, Joanna L. Elson & Ilse S. Pienaar. 2021. Mitochondrial Medicine. Mitochondrial Medicine 299 329 .
Elisa Panzarini, Stefania Mariano, Stefano Tacconi, Elisabetta Carata, Ada Maria Tata & Luciana Dini. (2020) Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders. Nanomaterials 11:1, pages 2.
Crossref
Nadia S Hejazi. (2020) Visual Hallucinations and Impulse Control Disorder in Parkinson’s Disease. International Journal of Neuropsychopharmacology 23:10, pages 639-641.
Crossref
Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger & Susanne Gerber. (2020) Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale. Cells 9:12, pages 2642.
Crossref
Meena S. Subbarayan, Charles Hudson, Lauren D. Moss, Kevin R. Nash & Paula C. Bickford. (2020) T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease. Journal of Neuroinflammation 17:1.
Crossref
Tao JinJiachen GuHongbo XiaHuimin ChenXiaomin XuZongshan LiYumei YueYaxing Gui. (2020) Differential Expression of microRNA Profiles and Wnt Signals in Stem Cell-Derived Exosomes During Dopaminergic Neuron Differentiation . DNA and Cell Biology 39:12, pages 2143-2153.
Crossref
Valeria Valadez-Barba, A. Cota-Coronado, O.R. Hernández-Pérez, Pavel H. Lugo-Fabres, Eduardo Padilla-Camberos, Néstor Fabián Díaz & N. Emmanuel Díaz-Martínez. (2020) iPSC for modeling neurodegenerative disorders. Regenerative Therapy 15, pages 332-339.
Crossref
Anita Pal, Nishi Pegwal, Madhuri Behari & Ratna Sharma. (2020) High delta and gamma EEG power in resting state characterise dementia in Parkinson’s patients. Biomarkers in Neuropsychiatry 3, pages 100027.
Crossref
Alex Frid & Larry M. Manevitz. (2019) Analyzing cognitive processes from complex neuro-physiologically based data: some lessons. Annals of Mathematics and Artificial Intelligence 88:11-12, pages 1125-1153.
Crossref
Ying Zhang, Xinyang Xie, Jiangnan Hu, Kazi Sabrina Afreen, Chun-Li Zhang, Qichuan Zhuge & Jianjing Yang. (2020) Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models. Frontiers in Neuroscience 14.
Crossref
Anna Picca, Flora Guerra, Riccardo Calvani, Hélio José Coelho-Júnior, Francesco Landi, Roberto Bernabei, Roberta Romano, Cecilia Bucci & Emanuele Marzetti. (2020) Extracellular Vesicles and Damage-Associated Molecular Patterns: A Pandora’s Box in Health and Disease. Frontiers in Immunology 11.
Crossref
Alberto Siddu, Linda Suzanne David, Nadine Lauinger, Xiuqing Chen, Martine Saint-Pierre, Melanie Alpaugh, Thomas Durcan & Francesca Cicchetti. (2020) Beneficial effects of cysteamine in Thy1-α-Syn mice and induced pluripotent stem cells with a SNCA gene triplication. Neurobiology of Disease 145, pages 105042.
Crossref
Marlaina R. Stocco, Cole Tolledo, Fariba Baghai Wadji, Frank J. Gonzalez, Sharon Miksys & Rachel F. Tyndale. (2020) Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice. Molecular Neurobiology 57:11, pages 4608-4621.
Crossref
Kasthuri Bai Magalingam, Ammu Kutty Radhakrishnan, Sushela Devi Somanath, Shadab Md & Nagaraja Haleagrahara. (2020) Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line. Molecular Biology Reports 47:11, pages 8775-8788.
Crossref
Mariafrancesca Cascione, Valeria De Matteis, Stefano Leporatti & Rosaria Rinaldi. (2020) The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Runxiao Lv, Lili Du, Fenghua Zhou, Xiangnan Yuan, Xueyong Liu & Lixin Zhang. (2020) Rosmarinic Acid Alleviates Inflammation, Apoptosis, and Oxidative Stress through Regulating miR-155-5p in a Mice Model of Parkinson’s Disease. ACS Chemical Neuroscience 11:20, pages 3259-3266.
Crossref
E. Maruthi Prasad & Shih-Ya Hung. (2020) Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease. Antioxidants 9:10, pages 1007.
Crossref
Indrani Ghosh, Runali Sankhe, Jayesh Mudgal, Devinder Arora & Madhavan Nampoothiri. (2020) Spermidine, an autophagy inducer, as a therapeutic strategy in neurological disorders. Neuropeptides 83, pages 102083.
Crossref
Yu Zhang & Marc A. Burock. (2020) Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review. Frontiers in Neurology 11.
Crossref
Xin‐yi Chai, Shanti Diwakarla, Ruslan V. Pustovit, Rachel M. McQuade, Madeleine Di Natale, Charlotte M. Ermine, Clare L. Parish, David I. Finkelstein & John B. Furness. (2020) Investigation of nerve pathways mediating colorectal dysfunction in Parkinson’s disease model produced by lesion of nigrostriatal dopaminergic neurons. Neurogastroenterology & Motility 32:9.
Crossref
Jenjira Thanakamchokchai, Jarugool Tretriluxana, Narawut Pakaprot, Apichart Pisarnpong & Beth E. Fisher. (2020) Effects of high-frequency repetitive transcranial magnetic stimulation on reach-to-grasp performance in individuals with Parkinson’s disease: a preliminary study. Experimental Brain Research 238:9, pages 1827-1837.
Crossref
Marina Izvolskaia, Viktoriya Sharova & Liudmila Zakharova. (2020) Perinatal Inflammation Reprograms Neuroendocrine, Immune, and Reproductive Functions: Profile of Cytokine Biomarkers. Inflammation 43:4, pages 1175-1183.
Crossref
Sudip Mukherjee, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, Sayan Roy Chowdhury, Manash Kumar Paul & Anubhab Mukherjee. (2020) Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Advanced Functional Materials 30:35.
Crossref
Anna Picca, Riccardo Calvani, Hélio José Coelho-Junior, Francesco Landi, Roberto Bernabei & Emanuele Marzetti. (2020) Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants 9:8, pages 647.
Crossref
Julien Abrossimoff, Alexandre Pitti & Philippe Gaussier. (2020) Working-memory prefrontal model for cognitive flexibility in task-switching and selection. Working-memory prefrontal model for cognitive flexibility in task-switching and selection.
Matthias Kirschner, Arielle Rabinowitz, Neomi Singer & Alain Dagher. (2020) From apathy to addiction: Insights from neurology and psychiatry. Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, pages 109926.
Crossref
Aryendu K. Saini, Rakesh Saini, Himanshu Bansode, Anurag Singh & Lalita Singh. (2020) Stem Cells: A Review Encompassing the Literature with a Special Focus on the Side-Lined Miraculous Panacea; Pre-Morula Stem Cells. Current Stem Cell Research & Therapy 15:4, pages 379-387.
Crossref
Ashok Chakraborty, Sam Brauer & Anil Diwan. (2020) A review of possible therapies for Parkinson’s disease. Journal of Clinical Neuroscience 76, pages 1-4.
Crossref
Albin John, Aaron Kubosumi & P. Hemachandra Reddy. (2020) Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases. Cells 9:6, pages 1345.
Crossref
Ashok Chakraborty, Sam Brauer & Anil Diwan. (2020) Possible therapies of Parkinson’s disease: A review. Journal of Clinical Neuroscience 75, pages 1-4.
Crossref
Muhammad Imran Razzak, Muhammad Imran & Guandong Xu. (2019) Big data analytics for preventive medicine. Neural Computing and Applications 32:9, pages 4417-4451.
Crossref
Javor Mitkov, Alexandra Kasabova-Angelova, Magdalena Kondeva-Burdina, Virginia Tzankova, Diana Tzankova, Maya Georgieva & Alexander Zlatkov. (2020) Design, Synthesis and Evaluation of 8-Thiosubstituted 1,3,7- Trimethylxanthine Hydrazones with In-vitro Neuroprotective and MAO-B Inhibitory Activities. Medicinal Chemistry 16:3, pages 326-339.
Crossref
Francesco Di Meo, Anna Valentino, Orsolina Petillo, Gianfranco Peluso, Stefania Filosa & Stefania Crispi. (2020) Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration. International Journal of Molecular Sciences 21:7, pages 2564.
Crossref
Jaya Sanyal, Athira Anirudhan, Tapas Kumar Banerjee, Gautam Guha, Ramakrishnan Veerabathiran, Ram Murugesan, S. S. J. Shiek Ahmed & Vadlamudi Raghavendra Rao. (2019) PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson’s Disease. Cellular and Molecular Neurobiology 40:3, pages 357-367.
Crossref
Oscar F. Sánchez, Andrea V. Rodríguez, José M. Velasco-España, Laura C. Murillo, Jhon-Jairo Sutachan & Sonia-Luz Albarracin. (2020) Role of Connexins 30, 36, and 43 in Brain Tumors, Neurodegenerative Diseases, and Neuroprotection. Cells 9:4, pages 846.
Crossref
Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger & John B. Furness. (2019) Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease. Neurogastroenterology & Motility 32:3.
Crossref
Hea-Jong Chung, Md. Saidul Islam, Md. Mashiar Rahman & Seong-Tshool Hong. (2020) Neuroprotective function of Omi to α-synuclein-induced neurotoxicity. Neurobiology of Disease 136, pages 104706.
Crossref
Pradeep Paudel, Se Eun Park, Su Hui Seong, Hyun Ah Jung & Jae Sue Choi. (2020) Bromophenols from Symphyocladia latiuscula Target Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases . Journal of Agricultural and Food Chemistry 68:8, pages 2426-2436.
Crossref
Abhinaba Ghosh, Saibal Das, Sapan Kumar Behera, Kirubakaran Ramakrishnan, Sandhiya Selvarajan, Preeti Kandasamy & N Sreekumaran Nair. (2020) Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson’s Disease Patients with Cognitive Deficits: A Meta-Analysis. Parkinson's Disease 2020, pages 1-8.
Crossref
Anna Picca, Flora Guerra, Riccardo Calvani, Federico Marini, Alessandra Biancolillo, Giovanni Landi, Raffaella Beli, Francesco Landi, Roberto Bernabei, Anna Bentivoglio, Maria Lo Monaco, Cecilia Bucci & Emanuele Marzetti. (2020) Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson’s Disease: Results from the EXosomes in PArkiNson’s Disease (EXPAND) Study. Journal of Clinical Medicine 9:2, pages 504.
Crossref
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Ho-Won Lee & Dong-Kug Choi. (2020) Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies. Biomaterials 232, pages 119704.
Crossref
Chellappan Praveen Rajneesh, Tsung-Hsun Hsieh, Shih-Ching Chen, Chien-Hung Lai, Ling-Yu Yang, Hung-Yen Chin & Chih-Wei Peng. (2020) Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus Renders Neuroprotection through the Suppression of Hippocampal Apoptosis: An Experimental Animal Study. Brain Sciences 10:1, pages 25.
Crossref
Mukesh Pandey, Jahangir Nabi, Nahida Tabassum, Faheem Hyder Pottoo, Renuka Khatik & Niyaz Ahmad. 2020. Quality Control of Cellular Protein in Neurodegenerative Disorders. Quality Control of Cellular Protein in Neurodegenerative Disorders 354 379 .
Mahsa Khosravi, S. Farokh Atashzar, Greydon Gilmore, Mandar S. Jog & Rajni V. Patel. (2020) Intraoperative Localization of STN During DBS Surgery Using a Data-Driven Model. IEEE Journal of Translational Engineering in Health and Medicine 8, pages 1-9.
Crossref
Akanksha Mishra, Sonu Singh, Virendra Tiwari, Shameema Bano & Shubha Shukla. (2020) Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson’s disease. Behavioural Brain Research 378, pages 112304.
Crossref
Akhlaq A. Farooqui. 2020. Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders. Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders 293 347 .
Sunpreet Kaur, Shamsher Singh, Anchal Arora, Parladh Ram, Sachin Kumar, Puneet Kumar & Sara Nidal Abed. 2020. Frontiers in Pharmacology of Neurotransmitters. Frontiers in Pharmacology of Neurotransmitters 241 292 .
Xiaolu Liu, Zhitao Feng, Lipeng Du, Yaguang Huang, Jinwen Ge, Yihui Deng & Zhigang Mei. (2019) The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury. International Journal of Molecular Sciences 21:1, pages 120.
Crossref
Efthalia Angelopoulou, Yam Nath Paudel & Christina Piperi. (2019) miR-124 and Parkinson’s disease: A biomarker with therapeutic potential. Pharmacological Research 150, pages 104515.
Crossref
Anna Picca, Riccardo Calvani, Giovanni Landi, Federico Marini, Alessandra Biancolillo, Jacopo Gervasoni, Silvia Persichilli, Aniello Primiano, Andrea Urbani, Maurizio Bossola, Anna Rita Bentivoglio, Matteo Cesari, Francesco Landi, Roberto Bernabei, Emanuele Marzetti & Maria Rita Lo Monaco. (2019) Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study. Experimental Gerontology 128, pages 110766.
Crossref
Hussaini Adam, Subash C.B. Gopinath, M.K. Md Arshad, Tijjani Adam & Uda Hashim. (2019) Perspectives of nanobiotechnology and biomacromolecules in parkinson’s disease. Process Biochemistry 86, pages 32-39.
Crossref
Pedram G. Renani, Forogh Taheri, Daryoush Rostami, Najmeh Farahani, Hamed Abdolkarimi, Elahe Abdollahi, Eskandar Taghizadeh & Seyed Mohammad Gheibi Hayat. (2019) Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic‐based therapies. Journal of Cellular Physiology 234:11, pages 19307-19319.
Crossref
Maria Concetta Scuto, Cesare Mancuso, Barbara Tomasello, Maria Laura Ontario, Andrea Cavallaro, Francesco Frasca, Luigi Maiolino, Angela Trovato Salinaro, Edward J. Calabrese & Vittorio Calabrese. (2019) Curcumin, Hormesis and the Nervous System. Nutrients 11:10, pages 2417.
Crossref

Displaying 200 of 297 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.